Showing results (1-10 of 6,541) with videos related to
Sort By:
Pageof 655
Cancer|December 1, 1979
Nodular malignant lymphomas: factors affecting complete response rate and survivalF Cabanillas, T Smith, G P Bodey, et al.Cancer|December 1, 1980
Management with chemotherapy only of stage I and II malignant lymphoma of aggressive histologic typesF Cabanillas, G P Bodey, E J FreireichJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1986
A 10-year update of CHOP-Bleo in the treatment of diffuse large-cell lymphomaR Lee, F Cabanillas, G P Bodey, et al.The American Journal of Medicine|January 1, 1979
Protected environment-prophylactic antibiotic program for malignant lymphoma. Randomized trial during chemotherapy to induce remissionG P Bodey, V Rodriguez, F Cabanillas, et al.The American Journal of Medicine|March 1, 1983
Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic typeF Cabanillas, M A Burgess, G P Bodey, et al.Blood|September 1, 1982
IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapyF Cabanillas, F B Hagemeister, G P Bodey, et al.Cancer Treatment Reports|March 1, 1979
Results of a phase II study of maytansine in patients with breast carcinoma and melanomaF Cabanillas, G P Bodey, M A Burgess, et al.Blood|March 1, 1981
Initial experience with AMSA as single agent treatment against malignant lymphoproliferative disordersF Cabanillas, S S Legha, G P Bodey, et al.Science (New York, N.Y.)|September 22, 1972
Antigen solubilized from human leukemia: lymphocyte stimulationJ U Gutterman, G Mavligit, K B McCredie, et al.Blood|December 1, 1979
Central nervous system relapse in malignant lymphomas: risk factors and implications for prophylaxisJ P Litam, F Cabanillas, T L Smith, et al.Pageof 655